X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Biocon Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON LTD
Mar-16
ADCOCK INGRAM
Jun-14
BIOCON LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs496316-   
Low Rs397228-   
Sales per share (Unadj.) Rs174.394.0-  
Earnings per share (Unadj.) Rs44.8-23.7-  
Cash flow per share (Unadj.) Rs56.9-19.6-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs202.873.8-  
Shares outstanding (eoy) m200.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.62.9 88.5%   
Avg P/E ratio x10.0-11.5 -86.7%  
P/CF ratio (eoy) x7.8-13.9 -56.6%  
Price / Book Value ratio x2.23.7 59.7%  
Dividend payout %11.20-   
Avg Mkt Cap Rs m89,22045,919 194.3%   
No. of employees `0004.44.3 102.8%   
Total wages/salary Rs m6,3632,882 220.8%   
Avg. sales/employee Rs Th7,894.53,696.8 213.5%   
Avg. wages/employee Rs Th1,441.2671.3 214.7%   
Avg. net profit/employee Rs Th2,029.7-931.5 -217.9%   
INCOME DATA
Net Sales Rs m34,85415,870 219.6%  
Other income Rs m845111 760.3%   
Total revenues Rs m35,69915,982 223.4%   
Gross profit Rs m8,200-2,750 -298.2%  
Depreciation Rs m2,423685 353.7%   
Interest Rs m102430 23.7%   
Profit before tax Rs m6,520-3,754 -173.7%   
Minority Interest Rs m-744-10 7,110.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5,7540-   
Tax Rs m2,569235 1,095.2%   
Profit after tax Rs m8,961-3,999 -224.1%  
Gross profit margin %23.5-17.3 -135.8%  
Effective tax rate %39.4-6.2 -630.6%   
Net profit margin %25.7-25.2 -102.0%  
BALANCE SHEET DATA
Current assets Rs m39,93211,624 343.5%   
Current liabilities Rs m16,2766,540 248.9%   
Net working cap to sales %67.932.0 211.9%  
Current ratio x2.51.8 138.0%  
Inventory Days Days54111 48.3%  
Debtors Days Days86124 69.5%  
Net fixed assets Rs m39,1016,775 577.1%   
Share capital Rs m1,00074 1,357.1%   
"Free" reserves Rs m38,5910-   
Net worth Rs m40,55612,457 325.6%   
Long term debt Rs m20,7244,377 473.4%   
Total assets Rs m84,81623,531 360.4%  
Interest coverage x64.9-7.7 -839.6%   
Debt to equity ratio x0.50.4 145.4%  
Sales to assets ratio x0.40.7 60.9%   
Return on assets %10.7-15.2 -70.5%  
Return on equity %22.1-32.1 -68.8%  
Return on capital %19.0-19.8 -95.8%  
Exports to sales %30.70-   
Imports to sales %20.40-   
Net fx Rs m3,3960-   
CASH FLOW
From Operations Rs m5,2641,355 388.6%  
From Investments Rs m-9,540-416 2,293.6%  
From Financial Activity Rs m10,8673,973 273.5%  
Net Cashflow Rs m6,5914,912 134.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.36 Rs / ZAR

Compare BIOCON LTD With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON LTD With: PANACEA BIOTECH  J.B.CHEMICALS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views On News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 17, 2017 02:10 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD 8-QTR ANALYSIS

COMPARE BIOCON LTD WITH

MARKET STATS